T

Technology Drug Discovery

$EWSAIDRUGSEEureka Wealth

About Technology Drug Discovery

Technology and especially AI allow for advanced simulations to significantly speed up the traditional lab-based process of drug discovery. These companies lead the next wave of biotech.

About the Creator

Igor Tsukerman is a cofounder, CEO, and Chief Investment Officer of Eureka Wealth Solutions. Founded in 2014 and based in New York, Eureka offers a broad spectrum of traditional wealth management services and specialize in thematic investing. Identifying a trend early - due to innovation, social, demographic, economic, geopolitical, regulatory, or other reason - and investing in a portfolio of its biggest beneficiaries often leads to market outperformance. With nearly 30 years of investing experience and career spanning 15 years in biggest Wall Street companies, tech startups, running a hedge fund, and now leading a wealth management company, Igor is well-positioned and has a track record in thematic investing space.

Activity

Total Rebalances1
Last RebalanceMar 4, 2026

Posts by Creator

Changes:BNTX +13.0%MRNA +13.0%ROIV +11.2%SMMT +9.0%ARQT +8.3%

$EWSAIDRUGS Adding recent IPO EIKN, also adding small stakes in top 3 big pharmas by AI usage, trimming top holdings